Literature DB >> 7848319

Long-term survival in systemic lupus erythematosus. Patient characteristics associated with poorer outcomes.

M M Ward1, E Pyun, S Studenski.   

Abstract

OBJECTIVE: To investigate the associations of age, sex, race, and socioeconomic status with long-term survival in patients with systemic lupus erythematosus (SLE).
METHODS: We examined survival in an inception cohort of 408 patients with SLE. The cohort included 177 black females, 162 white females, 49 white males, and 20 black males. The median duration of followup was 11 years (range 0.1-22 years).
RESULTS: One hundred forty-four patients died during the study. The 5-, 10-, and 15-year survival estimates for the entire cohort were 82%, 71%, and 63%, respectively. In univariate analyses, mortality rates increased with age and were higher among males, blacks, those without private medical insurance, and those living in census tracts with lower household incomes. In multivariate analyses, age, sex, and both socioeconomic indicators were associated with total mortality (mortality from any cause), while race was not. Lower socioeconomic status and increased age were also associated with higher rates of death from SLE.
CONCLUSION: Socioeconomic status, but not race, is associated with mortality in SLE. SLE-related mortality also tends to increase with age, which suggests that SLE may not be less severe when it occurs later in life.

Entities:  

Mesh:

Year:  1995        PMID: 7848319     DOI: 10.1002/art.1780380218

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  50 in total

Review 1.  Recognition and management of systemic lupus erythematosus.

Authors:  J O Schroeder; H H Euler
Journal:  Drugs       Date:  1997-09       Impact factor: 9.546

2.  Neurofibromatosis and systemic lupus erythematosus. A matter of coincidence?

Authors:  Hèctor Corominas; Josep M Guardiola; Laia Matas; Guillermo Vázquez
Journal:  Clin Rheumatol       Date:  2003-10-14       Impact factor: 2.980

3.  Childhood-onset disease as a predictor of mortality in an adult cohort of patients with systemic lupus erythematosus.

Authors:  Aimee O Hersh; Laura Trupin; Jinoos Yazdany; Peter Panopalis; Laura Julian; Patricia Katz; Lindsey A Criswell; Edward Yelin
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-08       Impact factor: 4.794

4.  Ethnicity and mortality from systemic lupus erythematosus in the US.

Authors:  E Krishnan; H B Hubert
Journal:  Ann Rheum Dis       Date:  2006-04-20       Impact factor: 19.103

5.  Poverty, not ethnicity, accounts for the differential mortality rates among lupus patients of various ethnic groups.

Authors:  Sergio Durán; Mandar Apte; Graciela S Alarcón
Journal:  J Natl Med Assoc       Date:  2007-10       Impact factor: 1.798

6.  A multicentre study of 513 Danish patients with systemic lupus erythematosus. II. Disease mortality and clinical factors of prognostic value.

Authors:  S Jacobsen; J Petersen; S Ullman; P Junker; A Voss; J M Rasmussen; U Tarp; L H Poulsen; G van Overeem Hansen; B Skaarup; T M Hansen; J Pødenphant; P Halberg
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

7.  Mixed connective tissue disease. A clinico-serological study of 17 cases.

Authors:  I García-de la Torre; M Salazar-Páramo; G Salmón-de la Torre
Journal:  Mol Biol Rep       Date:  1996       Impact factor: 2.316

8.  Work loss and work entry among persons with systemic lupus erythematosus: comparisons with a national matched sample.

Authors:  Edward Yelin; Chris Tonner; Laura Trupin; Pantelis Panopalis; Jinoos Yazdany; Laura Julian; Patricia Katz; Lindsey A Criswell
Journal:  Arthritis Rheum       Date:  2009-02-15

9.  Renal damage is the most important predictor of mortality within the damage index: data from LUMINA LXIV, a multiethnic US cohort.

Authors:  Maria I Danila; Guillermo J Pons-Estel; Jie Zhang; Luis M Vilá; John D Reveille; Graciela S Alarcón
Journal:  Rheumatology (Oxford)       Date:  2009-02-20       Impact factor: 7.580

10.  A national study of the complications of lupus in pregnancy.

Authors:  Megan E B Clowse; Margaret Jamison; Evan Myers; Andra H James
Journal:  Am J Obstet Gynecol       Date:  2008-05-05       Impact factor: 8.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.